Pharmaceutical firm Servier stands trial over killer diabetes-weight loss drug

Trial opens of French pharmaceutical firm Servier for hiding dangers of diabetes drug used to lose weight and blamed for causing at least 500 deaths.

Reading articles is for subscribers only. Subscribe now.

The first Fench trial has begun over a diabetes drug that was also used to lose weight and is suspected in the deaths of at least 500 people, reports The Washington Post.